Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 801 results for "bayer ag"

BRIEF-Bayer to early redeem 1.3 bln eur bond issued in 2005

April 15 (Reuters) - Bayer AG * To early redeem 1.3 billion euro bond issued in 2005 * Says first opportunity to repay the subordinated bond with a 5 pct coupon and a 100-year maturity issued in 2005 arises on July 29 Source text: ... Reuters UK, 4 days ago

58 images for bayer ag

American Banking News, 9 hours ago
Ticker Report, 13 hours ago
BioSpace, 5 days ago
American Banking News, 1 month ago
Mideast Time, 1 month ago
Social Dashboard, 1 week ago
European Coatings, 1 month ago
Irish Times, 1 month ago
Reuters India, 1 month ago
Automotive World, 1 month ago
SeedQuest

Global Seeds Market Report: 2015 Edition Featuring Bayer Crop Science, Syngenta, DuPont & Monsanto

Research and Markets (http://www.researchandmarkets.com/research/b2b6gl/global_seeds) has announced the addition of the "Global Seeds Market Report: 2015 Edition" report to their offering. Seed is the basic and most critical input for sustainable ...
 Individual.com6 days ago Research and Markets: Global Biological Seed Treatment Market 2015-2019 With BASF SE, Bayer CropScience, Monsanto, Valent Biosciences, Syngenta, Italpollina, Koppert B.V., Arysta LifeScience & Novozymes Dominating  Business Wire4 days ago Global Biological Seed Treatment Market 2015-2019 with BASF SE, Bayer CropScience, Monsanto, Valent Biosciences, Syngenta, Italpollina, Koppert B.V., Arysta LifeScience & Novozymes Dominating  Individual.com4 days ago RESEARCH AND MARKETS : Global Biological Seed Treatment Market 2015-2019 With BASF SE, Bayer CropScience, Monsanto, Valent Biosciences, Syngenta, Italpollina, Koppert B.V., Arysta LifeScience & Novozymes Dominating  4 Traders4 days ago
[x]  

BRIEF-Bayer to launch two late-stage trials of Copanlisib

April 14 (Reuters) - Bayer AG * Says to commence two Copanlisib Phase III studies on patients with indolent non-hodgkin lymphoma Further
 Reuters UK5 days ago
Social Dashboard

Bayer CEO Focuses On Company's Strengths

Bayer AG CEO Marijn Dekkers decision to narrow his company's focus to its core businesses of drugs and agricultural chemicals by spinning off its underperforming specialty plastics subsidiary is smart move that other leaders should be watching ...
 Forbes.com2 weeks ago Bayer's CEO Injects a Dose of U.S. Risk-Taking  Austin American Statesman2 weeks ago

Bayer not to acquire Omega Pharma

Perrigo Company plc, an Ireland-based manufacturer of over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, has acquired Omega Pharma NV, a Belgium-based manufacturer of OTC medicines and personal care products, from Omega Pharma ...
 Individual.com2 weeks ago
Business Standard

Patent office refuses patent for tosylate salt form of Bayer's sorafenib

The Indian Patent Office has refused patent application of German drug major Bayer Healthcare AG for a form of tosylate salt of its anticancer drug Sorafenib, known under the brand Nexavar, on the grounds of lack of inventive step and Section 3(d) ...
 Business Standard1 month ago

World Hemophilia Day: April 17, 2015: Bayer Joins Leading International Organizations to Empower Future Leaders in Hemophilia, Hematology and Thrombosis

/PRNewswire/ --In recognition of World Hemophilia Day and the global need for education about hemophilia, Bayer HealthCare will host an inaugural joint fellowship alumni event during the International Society of Thrombosis and Haemostasis (ISTH) ...
 Ulitzer2 days ago World Hemophilia Day: April 17 2015: Bayer Joins Leading International Organizations to Empower Future Leaders in Hemophilia Hematology and Thrombosis  PharmiWeb2 days ago
[x]  

Bayer HealthCare Announces Plans For Product Testing Facility In Berkeley, CA

Posted by Heidi Schwartz Photo: City of Berkeley/Bayer. BayerHealthCare hasannounced a $100 million investment in its Berkeley, CA manufacturing site to build a product testing facility that will support the next generation of treatments for ...
 Business Facilities2 days ago Bayer HealthCare Invests $100 Million in New Product Testing Facility to Support Emerging Generations of Hemophilia Treatments  Noodls4 days ago
[x]  
Pharmaceutical Business Review

Bayer expands copanlisib clinical development program for NHL treatment

Bayer HealthCare has expanded its global clinical development program for the investigational oncology compound copanlisib (BAY 80-6946) for the treatment of non-Hodgkin's lymphoma (NHL). Copanlisib is an intravenous pan-class I ...
 Pharmaceutical Business Review4 days ago Bayer HealthCare (BAY)'s Devises Phase III Plans for Top Prospect 4/14/2015  ClinicSpace5 days ago Bayer Advances Clinical Development Program for Investigational Cancer Drug Copanlisib  Wall Street Select5 days ago Bayer HealthCare Devises Phase III Plans for Top Prospect  BioSpace5 days ago
[x]  
Sys-Con Media

Bayer : Companion Vector-Borne Diseases Web Conference Advances 'One Health' Approach

Release date- 13042015 - Leverkusen, - Nearly half of the world's population is infected with at least one type of vector-borne disease(i). These diseases are transmitted from parasites to animals and humans, and have a significant impact on ...
 4 Traders5 days ago Bayer to educate physicians and veterinarians around the globe on vector-borne diseases  Sys-Con Media6 days ago Bayer AG To Educate Physicians And Veterinarians Around The Globe On Vector-Borne Diseases  BioSpace6 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - bayer ag
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less